John J. Schwartz, PhD
Chairman of the Board
President, Quantum Strategies Management
John Schwartz was elected to the Board of Directors of StemCells, Inc. in December 1998 and was elected
the Chairman of the Board at the same time. He is the former President and Chief Executive Officer of SyStemix, Inc.
Dr. Schwartz is currently the President of Quantum Strategies Management Company, a registered investment
advisor located in Palo Alto, California. Prior to his positions at SyStemix, he served as Assistant Professor, Vice
President and General Counsel at Stanford University in California. Dr. Schwartz graduated from Harvard Law
School in 1958 and received his Ph.D. degree in physics from the University of Rochester in 1965.
Back to Top
Eric H. Bjerkholt
Senior Vice President and CFO, Sunesis Pharmaceuticals, Inc.
Eric Bjerkholt was elected to the Board of Directors of StemCells, Inc. in March 2004. He is Senior Vice President
and Chief Financial Officer of Sunesis Pharmaceuticals, Inc., a small molecule biopharmaceutical company in South
San Francisco, California. Before joining Sunesis, Mr. Bjerkholt served as the Senior Vice President and Chief
Financial Officer of IntraBiotics Pharmaceuticals, Inc. Previously, Mr. Bjerkholt co-founded LifeSpring Nutrition,
Inc., a privately held nutraceutical company, and served as its Chief Financial Officer, and later as its President and
Chief Executive Officer. From 1990 to 1997, Mr. Bjerkholt was an investment banker at J.P. Morgan & Co., Inc.
Mr. Bjerkholt holds an M.B.A. from Harvard Business School and a Cand. Oecon degree in economics and
econometrics from the University of Oslo, Norway. He is a member of the board of directors of Round Table Pizza,
Back to Top
Ricardo B. Levy, PhD
Retired Founder, Chairman & CEO, Catalytica, Inc.
Ricardo Levy was elected to the Board of Directors of StemCells, Inc. in September 2001. He most recently served as Lead Director of Renegy Holdings, the successor of Catalytica Energy Systems, Inc., an environmental emissions solutions provider. Prior to his role with Renegy Holdings, Dr. Levy served as Chairman of the Board of Catalytica Energy Systems from 1995, when the company was formed as a subsidiary of Catalytica, Inc., until October 2007 when the company merged to form Renegy. Dr. Levy was a founder of Catalytica, Inc. in 1974, serving as Chief Operating Officer from 1974 until 1991, and President and Chief Executive Officer until December 2000, when Catalytica, Inc. and its subsidiary Catalytica Pharmaceuticals, Inc. were sold to DSM N.V. Before founding Catalytica, Inc., Dr. Levy was a founding member of Exxon’s chemical physics research team, and prior to that served as Chief Executive Officer of Sudamericana C.A. in Quito, Ecuador. He continues to serve as Special Advisor to the Board of Directors of Renegy Holdings, and also as a member of the Board of Directors of Accelrys Inc. (formerly Pharmacopeia, Inc.) and NovoDynamics, Inc., a private company focused on advanced image discovery. Dr. Levy holds Bachelor of Science and PhD degrees in Chemical Engineering from Stanford University, and a Master of Science Degree from Princeton University.
Back to Top